• Home
  • Search Results
  • Odour concentration-dependent olfactory preference change in C. elegans.

Odour concentration-dependent olfactory preference change in C. elegans.

Nature communications (2012-03-15)
Kazushi Yoshida, Takaaki Hirotsu, Takanobu Tagawa, Shigekazu Oda, Tokumitsu Wakabayashi, Yuichi Iino, Takeshi Ishihara

The same odorant can induce attractive or repulsive responses depending on its concentration in various animals including humans. However, little is understood about the neuronal basis of this behavioural phenomenon. Here we show that Caenorhabditis elegans avoids high concentrations of odorants that are attractive at low concentrations. Behavioural analyses and computer simulation reveal that the odour concentration-dependent behaviour is primarily generated by klinokinesis, a behavioural strategy in C. elegans. Genetic analyses and lesion experiments show that distinct combinations of sensory neurons function at different concentrations of the odorant; AWC and ASH sensory neurons have critical roles for attraction to or avoidance of the odorant, respectively. Moreover, we found that AWC neurons respond to only lower concentrations of the odorant, whereas ASH neurons respond to only higher concentrations of odorant. Hence, our study suggests that odour concentration coding in C. elegans mostly conforms to the labelled-line principle where distinct neurons respond to distinct stimuli.

Product Number
Product Description

3-Methyl-1-butanol, anhydrous, ≥99%
Isoamyl alcohol, ≥98%, FG
3-Methylbutanol, BioReagent, for molecular biology, ≥98.5%
3-Methyl-1-butanol, reagent grade, 98%
Isoamyl alcohol, natural, ≥98%, FG
3-Methylbutanol, puriss. p.a., ACS reagent, ≥98.5% (GC)
3-Methyl-1-butanol, ACS reagent, ≥98.5%
3-Methylbutanol, BioUltra, for molecular biology, ≥99.0% (GC)
3-Methylbutanol, analytical standard

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.